- MarketWatch•7 hours ago
The drugmaker could face a mixed quarter, analysts say.
- TheStreet.com•8 hours ago
Estimates for erenumab annual sales run as high as $2.3 billion.
- Motley Fool•15 hours ago
A big dividend raise isn't always the right move for a business.
AMGN : Summary for Amgen Inc. - Yahoo Finance
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||164.90 x 400|
|Ask||167.00 x 1400|
|Day's Range||163.41 - 165.29|
|52 Week Range||133.64 - 184.21|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.08|
|Dividend & Yield||4.60 (2.84%)|
|1y Target Est||N/A|